# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jean-Jacques Rousseau (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN003-SYN
- Date: 2026-04-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celestine Marchetti-Owusu, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review four weeks after urethroplasty; wants to try the medicine for sleep and worry. **S**

## History of present illness

Mr. Rousseau returns four weeks after an excision and primary anastomosis bulbar urethroplasty. The pathology showed dense fibrosis of the corpus spongiosum without inflammation or malignancy. The catheter came out a week ago after a urethrogram around it showed no leak. He now passes urine with what he calls a stream he has not had since childhood, empties fully, and gets up once at night. The perineal wound is healed; he takes acetaminophen once a day at most. He has had seven sessions of CBT for psychosis. He says the beliefs still weigh on him at night and he sleeps about five hours, and that, now his bladder no longer wakes him, he wants to see whether the medicine he was offered helps his sleep and worry. He has had no thoughts of suicide or of harming anyone. **S**

| Element | Detail |
|---|---|
| Surgery | Anastomotic bulbar urethroplasty four weeks ago; catheter out a week ago with no leak |
| Voiding | Free stream; up once at night |
| Psychotherapy | Seven CBT sessions |
| Medication decision | Asks to start aripiprazole |
| Safety | No thoughts of suicide or of harming anyone |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Genitourinary | Negative | Strong stream, empties fully, no burning, no blood; erections unchanged |
| Integumentary | Negative | Perineal wound healed |
| Neurological | Negative | No tremor, stiffness, restlessness, or abnormal movements |
| Psychiatric | Positive | Persecutory beliefs and night-time worry; no hallucinations; no thoughts of suicide or of harming anyone |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a day **S**
- Aripiprazole 5 mg oral tablet, one tablet by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/78 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 63.2 kg; BMI 22.9 kg/m². All vital signs are synthetic.

IPSS symptom score: 6; IPSS quality-of-life score: 2; Maximum urine flow (uroflowmetry): 21.5 mL/s; Post-void residual (bladder scan): 25 mL; PHQ-9: 6; Creatinine: 0.98 mg/dL; eGFR: 92 mL/min/1.73 m²; Glucose (fasting): 92 mg/dL; Hemoglobin A1c: 5.4%; Total cholesterol: 196 mg/dL; HDL cholesterol: 48 mg/dL; LDL cholesterol: 122 mg/dL; Triglycerides: 130 mg/dL; Waist circumference: 92 cm. All results are synthetic.

## Change since baseline

- IPSS symptom score: 24 at baseline, 6 at this visit **S**
- IPSS quality-of-life score: 5 at baseline, 2 at this visit **S**
- Maximum urine flow (uroflowmetry): 6.2 mL/s (low) at baseline, 21.5 mL/s at this visit **S**
- Post-void residual (bladder scan): 180 mL (high) at baseline, 25 mL at this visit **S**
- PHQ-9: 8 at baseline, 6 at this visit **S**
- Creatinine: 1.02 mg/dL at baseline, 0.98 mg/dL at this visit **S**
- eGFR: 87 mL/min/1.73 m² at baseline, 92 mL/min/1.73 m² at this visit **S**
- Glucose (fasting): 93 mg/dL at baseline, 92 mg/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well and cheerful about his bladder |
| Genitourinary | Perineal incision healed; no swelling or tenderness; right inguinal hernia small and reducible |
| Neurological | No tremor, rigidity, or involuntary movements; AIMS total 0 at baseline |
| Mental status | Calm and courteous; mood "better by day, troubled at night"; persecutory beliefs unchanged in content; no hallucinations; no suicidal or violent ideation; capacity for the medication decision present |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Bulbar urethral stricture after urethroplasty** (N35.812). Excellent early result: maximum flow 21.5 mL/s, residual 25 mL, IPSS 6 with a quality-of-life score of 2. Creatinine 0.98 mg/dL. **S**
   - No sounds or self-dilation ever again; tell the clinic if the stream weakens.
   - Surveillance: symptoms, IPSS, uroflowmetry, and residual at about 3, 6, and 12 months; urethroscopy or a urethrogram only if symptoms return or the flow falls.
2. **Delusional disorder, persecutory type** (F22). Partial benefit from CBT for psychosis in distress and checking, but the beliefs and night-time preoccupation persist, and sleep is still short. PHQ-9 6. He now chooses to try an antipsychotic after hearing the expected benefits (less preoccupation and distress in many people with delusional disorder, though the beliefs often remain) and the risks (restlessness, nausea, weight and metabolic change, and rarely movement disorders). Aripiprazole is chosen because it has little anticholinergic effect, which matters for a man whose bladder has only just begun to empty, and little sedation or weight gain. Baseline: weight 63.2 kg, BMI 22.9, waist 92 cm, blood pressure 124/78, fasting glucose 92 mg/dL, hemoglobin A1c 5.4 percent, LDL cholesterol 122 mg/dL, AIMS 0. **S**
   - Aripiprazole 5 mg each morning.
   - Call the clinic for restlessness, muscle stiffness, or new urges or compulsions such as gambling or spending.
   - Weight at 4, 8, and 12 weeks; fasting glucose, hemoglobin A1c, lipids, waist, and blood pressure at 12 weeks; AIMS every 6 months.
   - Continue CBT for psychosis.
   - Safety plan reviewed and unchanged; the 988 Suicide & Crisis Lifeline confirmed.
3. **Right inguinal hernia** (K40.90). Unchanged and painless; straining has stopped. **S**
   - Watchful waiting.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Suicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety plan | Every visit | Completed today | No thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed |
| Survey | PHQ-9 for depressive symptoms | At least monthly | Completed today | 6; the psychologist recorded 6 and 7 at sessions in March and April |
| Referral | Cognitive behavioral therapy for psychosis | About 16 sessions | Completed today | Seven sessions; continuing |
| Medication safety | Antipsychotic started by shared decision-making | When the patient chooses it | Completed today | Aripiprazole 5 mg started at his request after benefits and risks were discussed |
| Laboratory | Baseline fasting glucose, hemoglobin A1c, and lipids before a second-generation antipsychotic | Baseline, 12 weeks, then yearly | Completed today | Glucose 92 mg/dL, A1c 5.4 percent, total cholesterol 196, HDL 48, LDL 122, triglycerides 130 mg/dL |
| Examination | Baseline weight, BMI, waist, and blood pressure | Weight at baseline, 4, 8, and 12 weeks; waist and blood pressure at baseline and 12 weeks | Completed today | 63.2 kg, BMI 22.9, waist 92 cm, 124/78 mmHg |
| Examination | AIMS and akathisia check | AIMS at baseline and every 6 months; akathisia at each visit | Completed today | AIMS 0; no restlessness |
| Survey | IPSS and quality-of-life score after treatment | After treatment and at each surveillance visit | Completed today | IPSS 6; quality of life 2 |
| Imaging | Uroflowmetry and post-void residual after urethroplasty | After catheter removal, then at about 3, 6, and 12 months | Completed today | Maximum flow 21.5 mL/s; residual 25 mL |
| Imaging | Pericatheter urethrogram before catheter removal | About three weeks after anastomotic urethroplasty | Up to date | A week ago: no leak; catheter removed |
| Laboratory | Creatinine and eGFR | After relief of obstruction, and before metformin, NSAIDs, or contrast | Completed today | 0.98 mg/dL; eGFR 92 |
| Examination | Inguinal hernia check | At each review while under watchful waiting | Completed today | Unchanged |

## Goal progress

- Sleep at least six hours most nights. In progress; target 2026-07-14. **S**
- Less distress and preoccupation from the beliefs, so that he can write each morning and walk without fear. In progress; target 2026-07-14. **S**
- Stay in care: keep visits and psychotherapy sessions, with no sudden break in treatment. In progress; target 2026-12-15. **S**
- Pass urine with a free stream without self-dilation: maximum flow above 15 mL/s and post-void residual below 100 mL within three months of surgery. In progress; target 2026-07-14. **S**
- No harm to himself or anyone else; safety plan kept current. In progress; target 2026-12-15. **S**

## Medication changes

- Started: Aripiprazole 5 mg oral tablet, one tablet by mouth each morning **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020), American Psychiatric Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023), American Urological Association
- International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018), HerniaSurge Group (European Hernia Society and partner societies)

## Follow-up

- Weight check in four weeks; review at twelve weeks on aripiprazole with fasting blood tests and a flow test; CBT continues. **S**
- Next scheduled visit 2026-07-14: twelve-week aripiprazole and urethroplasty follow-up. **S**
